XML 51 R42.htm IDEA: XBRL DOCUMENT v3.22.2.2

Segment Information (as Restated) (Tables)

6 Months Ended

Jun. 30, 2022

Segment Reporting [Abstract]

Schedule of segment information

		During the Three-Month Period Ended June 30, 2022
		Scours				Mastitis				Other				Total
Product sales		$	3,823,466			$	37,834			$	72			$	3,861,372
Costs of goods sold			2,119,194				31,848				3,002				2,154,044
Gross margin			1,704,272				5,986				(2,930	)			1,707,328
OPERATING EXPENSES:
Product development expenses			8,188				1,102,939				27,640				1,138,767
Sales and marketing expenses			339,570				319,669				—				659,239
Administrative expenses			—				—				528,329				528,329
Operating expenses			347,758				1,422,608				555,969				2,326,335
NET OPERATING INCOME (LOSS)		$	1,356,514			$	(1,416,622	)		$	(558,899	)		$	(619,007	)

		During the Three-Month Period Ended June 30, 2021
		Scours				Mastitis				Other				Total
Product sales		$	4,472,947			$	29,211			$	39,652			$	4,541,810
Costs of goods sold			2,435,705				12,072				19,712				2,467,489
Gross margin			2,037,242				17,139				19,940				2,074,321
OPERATING EXPENSES:
Product development expenses			48				868,221				131,838				1,000,107
Sales and marketing expenses			352,510				84,472				—				436,982
Administrative expenses			—				—				421,724				421,724
Operating expenses			352,558				952,693				553,562				1,858,813
NET OPERATING INCOME (LOSS)		$	1,684,684			$	(935,554	)		$	(533,622	)		$	215,508

		Scours				Mastitis				Total
Total Assets as of June 30, 2022		$	23,923,884			$	22,059,965			$	45,983,849
Total Assets as of June 30, 2021		$	21,751,882			$	21,977,761			$	43,729,643
Depreciation and amortization expense during the three-month period ended June 30, 2022		$	315,557			$	315,742			$	631,299
Depreciation and amortization expense during the three-month period ended June 30, 2021		$	263,118			$	361,145			$	624,263
Capital Expenditures during the three-month period ended June 30, 2022		$	664,415			$	278,875			$	943,290
Capital Expenditures during the three-month period ended June 30, 2021		$	284,485			$	594,854			$	879,339

		During the Six-Month Period Ended June 30, 2022
		Scours				Mastitis				Other				Total
Product sales		$	9,786,341			$	73,260			$	1,455			$	9,861,056
Costs of goods sold			4,971,523				58,650				20,332				5,050,505
Gross margin			4,814,818				14,610				(18,877	)			4,810,551
OPERATING EXPENSES:
Product development expenses			16,596				2,085,075				73,031				2,174,702
Sales and marketing expenses			758,238				712,502				—				1,470,740
Administrative expenses			—				—				1,213,508				1,213,508
Operating expenses			774,834				2,797,577				1,286,539				4,858,950
NET OPERATING INCOME (LOSS)		$	4,039,984			$	(2,782,967	)		($	1,305,416	)		$	(48,399	)

		During the Six-Month Period Ended June 30, 2021
		Scours				Mastitis				Other				Total
Product sales		$	8,496,419			$	67,240			$	85,297			$	8,648,956
Costs of goods sold			4,887,864				48,050				36,532				4,972,446
Gross margin			3,608,555				19,190				48,765				3,676,510
OPERATING EXPENSES:
Product development expenses			7,532				1,836,292				187,347				2,031,171
Sales and marketing expenses			783,664				173,916				—				957,580
Administrative expenses			—				—				846,876				846,876
Operating expenses			791,196				2,010,208				1,034,223				3,835,627
NET OPERATING INCOME (LOSS)		$	2,817,359			$	(1,991,018	)		$	(985,458	)		$	(159,117	)

		Scours				Mastitis				Total
Total Assets as of June 30, 2022		$	23,923,884			$	22,059,965			$	45,983,849
Total Assets as of June 30, 2021		$	21,751,882			$	21,977,761			$	43,729,643
Depreciation and amortization expense during the six-month period ended June 30, 2022		$	624,077			$	630,750			$	1,254,827
Depreciation and amortization expense during the six-month period ended June 30, 2021		$	527,312			$	718,382			$	1,245,694
Capital Expenditures during the six-month period ended June 30, 2022		$	1,404,882			$	345,904			$	1,750,786
Capital Expenditures during the six-month period ended June 30, 2021		$	633,801			$	594,854			$	1,228,655

		During the Year Ended December 31, 2021
		Scours				Mastitis				Other				Total
Product sales		$	18,933,092			$	143,280			$	166,597			$	19,242,969
Costs of goods sold			10,411,936				99,957				75,147				10,587,040
Gross margin			8,521,156				43,323				91,450				8,655,929
OPERATING EXPENSES:
Product development expenses			25,374				3,887,781				255,363				4,168,518
Sales and marketing expenses			1,942,391				561,535				—				2,503,926
Administrative expenses			—				—				1,726,100				1,726,100
Operating expenses			1,967,765				4,449,316				1,981,463				8,398,544
NET OPERATING INCOME (LOSS)		$	6,553,391			$	(4,405,993	)		$	(1,890,013	)		$	257,385

		During the Year Ended December 31, 2020
		Scours				Mastitis				Other				Total
Product sales		$	15,072,446			$	136,210			$	133,548			$	15,342,204
Costs of goods sold			8,285,073				119,329				74,976				8,479,378
Gross margin			6,787,373				16,881				58,572				6,862,826
OPERATING EXPENSES:
Product development expenses			106,393				4,022,712				225,522				4,354,627
Sales and marketing expenses			2,119,289				48,610				—				2,167,899
Administrative expenses			—				—				1,720,653				1,720,653
Operating expenses			2,225,682				4,071,322				1,946,175				8,243,179
NET OPERATING INCOME (LOSS)		$	4,561,691			$	(4,054,441	)		$	(1,887,603	)		$	(1,380,353	)

		Scours				Mastitis				Total
Total Assets as of December 31, 2021		$	22,442,944			$	22,022,744			$	44,465,688
Total Assets as of December 31, 2020		$	18,416,157			$	21,933,437			$	40,349,594
Depreciation and amortization expense during the year ended December 31, 2021		$	1,094,810			$	1,374,171			$	2,468,981
Depreciation and amortization expense during the year ended December 31, 2020		$	1,002,360			$	1,447,647			$	2,450,007
Capital Expenditures during the year ended December 31, 2021		$	1,655,866			$	952,783			$	2,608,649
Capital Expenditures during the year ended December 31, 2020		$	3,456,307			$	616,232			$	4,072,539

X

- Definition

Tabular disclosure of the profit or loss and total assets for each reportable segment. An entity discloses certain information on each reportable segment if the amounts (a) are included in the measure of segment profit or loss reviewed by the chief operating decision maker or (b) are otherwise regularly provided to the chief operating decision maker, even if not included in that measure of segment profit or loss.

+ References

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 22
-URI https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 25
-URI https://asc.fasb.org/extlink&oid=126901519&loc=d3e8813-108599

Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 350
-SubTopic 20
-Section 50
-Paragraph 1
-URI https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267

Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 30
-URI https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599

+ Details

Name:	us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock
Namespace Prefix:	us-gaap_
Data Type:	dtr-types:textBlockItemType
Balance Type:	na
Period Type:	duration

X

- References

No definition available.

+ Details

Name:	us-gaap_SegmentReportingAbstract
Namespace Prefix:	us-gaap_
Data Type:	xbrli:stringItemType
Balance Type:	na
Period Type:	duration